Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: South Korea

Dongbu Bio-Health Care Securities Investment Trust 1 - Equity

+ Add to Watchlist

6170104:KS

1,141.47 KRW 7.76 0.68%

As of 05:07:26 ET on 04/01/2015.

Snapshot for Dongbu Bio-Health Care Securities Investment Trust 1 - Equity (6170104)

Year To Date: +22.09% 3-Month: +22.09% 3-Year: +12.58% 52-Week Range: 912.26 - 1,165.66
1-Month: +4.41% 1-Year: +23.40% 5-Year: +10.69% Beta vs KOSPI: 0.58

Mutual Fund Chart for 6170104

No chart data available.
  • 6170104:KS 1,141.47
  • 1M
  • 1Y
Interactive 6170104 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 6170104

Dongbu Bio-Health Care Securities Investment Trust 1 (Equity) is an open-end fund incorporated in South Korea. The Fund's objective is to achieve capital gains and current income. The Fund invests at least 50% of its total assets in Bio-Health Care stocks.

Inception Date: 11-03-2009 Telephone: 82-2-787-3700
Managers: YONG-NAM HAN
Web Site: www.dongbuam.co.kr

Fundamentals for 6170104

NAV (on 2015-04-01) 1,141.47
Assets (M) (on 2015-04-01) 81,195.32
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for 6170104

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-11-03) 103.96
Dividend Yield (ttm) 9.11

Fees & Expenses for 6170104

Front Load -
Back Load -
Current Mgmt Fee 0.72
Redemption Fee -
12b1 Fee -
Expense Ratio 1.29

Top Fund Holdings for 6170104

Filing Date: 11/30/2014
Name Position Value % of Total
HLB Inc 181,588 1,380,068,800 0.000%
Naturalendo Tech Co Ltd 19,244 1,029,554,000 0.000%
InBody Co Ltd 28,979 886,757,400 0.000%
JVM Co Ltd 14,001 828,859,200 0.000%
Chong Kun Dang Pharmaceutical 10,889 752,429,900 0.000%
Vieworks Co Ltd 22,674 748,242,000 0.000%
Chongkundang Holdings Corp 9,614 669,134,400 0.000%
Chabiotech Co Ltd 37,178 501,903,000 0.000%
Daewoong Pharmaceutical Co Ltd 7,221 480,918,600 0.000%
Devsisters Co Ltd 11,927 457,996,800 0.000%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil